Not available
Quote | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
Last: | $1.43 |
---|---|
Change Percent: | -3.27% |
Open: | $1.58 |
Close: | $1.43 |
High: | $1.58 |
Low: | $1.4201 |
Volume: | 119,059 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...
2024-05-14 20:48:10 ET TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Conference Call May 14, 2024 04:30 PM ET Company Participants Charles Theuer - President & CEO Scott Brown - CFO Conference Call Participants Matthew Venezia - Alliance Global...
Message Board Posts | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
Subject | By | Source | When |
---|---|---|---|
Bid 50 cent. | willlbone | investorshub | 04/26/2023 4:07:40 PM |
whytestocks: $TCON News Article - Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio | whytestocks | investorshangout | 04/06/2023 12:40:46 PM |
Update: Arbitration decision likely in April. | Tartiaboy | investorshub | 04/04/2023 5:30:03 PM |
Major arbitration decision imminent. | Tartiaboy | investorshub | 03/30/2023 1:19:10 PM |
What do you think happens | shurtha2000 | investorshub | 03/30/2023 12:49:56 PM |
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
NASDAQ Market:
TRACON Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life...
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a c...